Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Scientific poster: Development of a robust and scalable hiPSC platform for the identification of efficacious and less toxic ASOs
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease